Efforts to tackle challenges in tablet manufacture are shaped by quality by design (QbD) and continuous manufacturing. Experts take a look at the journey travelled thus far and where pharmaceutical ...
The tableting science anti-research (TSAR) project seeks to understand why certain formulations stick to tablet tooling. This article provides an overview of I Holland's tableting science anti-stick ...
In the annals of napkin illustration, continuous drug tablet manufacturing may have only one entry: Fernando Muzzio’s 2003 depiction of a tableting line for Janet Woodcock, then head of the US Food ...
• Hovione and GEA further strengthened their partnership, resulting in the launch of the ConsiGma® CDC flex Continuous Tableting Technology and the installation of a lab-scale R&D rig in Hovione´s ...
Romaco Kilian recently got together with BASF to hold a two-day workshop on tablet development with digital tools. Around 50 people, mainly from the pharmaceutical industry, accepted the invitation to ...
The FDA recognises the value of continuous manufacturing and is working to raise the level of awareness of this technology amongst its review staff. As one initiative the 1st CONTINUOUS MANUFACTURING ...
SEATTLE, April 14, 2021, (PHARMIWEB) — Overview: A tableting agent is a substance used in formulation with active pharmaceutical ingredients in medications. It is otherwise called excipients. The ...
Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines ...
Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing ...
Guy Villax, CEO of Hovione, stands in the central hall of the company’s new R&D center in Lisbon. On the wall beside him is a mural with photographs commemorating the family-owned pharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results